Extra Strength Mapap

Product NDC
0904-1988
Requested package NDC
0904-1988-60
11-digit product format
009041988
Labeler code
0904
Product ID
0904-1988_7f6b7829-ee33-7c66-e053-2a91aa0a8f13
Type
HUMAN OTC DRUG
Nonproprietary name
ACETAMINOPHEN
Dosage form
TABLET
Route
ORAL
Labeler
Major Pharmaceuticals
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2011-05-04
Marketing end
2021-09-30
Substance
ACETAMINOPHEN
Active strength
500 mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0904-19880904-1988-60DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0904-1988-59EA - Each0904-198859e9faee-e3d5-4ff9-84b0-c685998bf69412013-02-11
0904-1988-60EA - Each0904-198882c955b4-0ef5-44b8-89c9-fec81f411a3f12013-02-11
0904-1988-61EA - Each0904-1988f8dac616-228c-4c6d-a729-89cc45c9a11d12013-02-13
0904-1988-80EA - Each0904-1988e2e14895-8674-4abc-b0dc-0a23d8e44d3212013-02-11

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DACETAMINOPHEN TABLET [CARDINAL HEALTH]11
ACETAMINOPHENACTIVE MOIETY362O9ITL9DACETAMINOPHEN TABLET [CARDINAL HEALTH]11
POVIDONESINACTIVE INGREDIENTFZ989GH94EACETAMINOPHEN TABLET [CARDINAL HEALTH]11
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2ACETAMINOPHEN TABLET [CARDINAL HEALTH]11
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJACETAMINOPHEN TABLET [CARDINAL HEALTH]11
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APACETAMINOPHEN TABLET [CARDINAL HEALTH]11
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [MAJOR PHARMACEUTICALS]7
ACETAMINOPHENACTIVE MOIETY362O9ITL9DEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [MAJOR PHARMACEUTICALS]7
POVIDONESINACTIVE INGREDIENTFZ989GH94EEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [MAJOR PHARMACEUTICALS]7
SODIUM STARCH GLYCOLATE TYPE A CORNINACTIVE INGREDIENTAG9B65PV6BEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [MAJOR PHARMACEUTICALS]7
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [MAJOR PHARMACEUTICALS]7
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [MAJOR PHARMACEUTICALS]7
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DACETAMINOPHEN TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]5
ACETAMINOPHENACTIVE MOIETY362O9ITL9DACETAMINOPHEN TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]5
12-HYDROXYSTEARIC ACIDINACTIVE INGREDIENT933ANU3H2SACETAMINOPHEN TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]5
POVIDONE K12INACTIVE INGREDIENT333AG72FWJACETAMINOPHEN TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]5
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2ACETAMINOPHEN TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]5
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJACETAMINOPHEN TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]5
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [PREFERRED PHARMACEUTICALS, INC.]2
ACETAMINOPHENACTIVE MOIETY362O9ITL9DEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [PREFERRED PHARMACEUTICALS, INC.]2
POVIDONESINACTIVE INGREDIENTFZ989GH94EEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [PREFERRED PHARMACEUTICALS, INC.]2
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2EXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [PREFERRED PHARMACEUTICALS, INC.]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [PREFERRED PHARMACEUTICALS, INC.]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [PREFERRED PHARMACEUTICALS, INC.]2
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
ACETAMINOPHENACTIVE MOIETY362O9ITL9DEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
POVIDONESINACTIVE INGREDIENTFZ989GH94EEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
SODIUM STARCH GLYCOLATE TYPE A CORNINACTIVE INGREDIENTAG9B65PV6BEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APEXTRA STRENGTH MAPAP (ACETAMINOPHEN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
198440acetaminophen 500 MG Oral TabletPSN72053f9e-cca7-7e8a-e053-2995a90a99f01
198440acetaminophen 500 MG Oral TabletPSNc952efb5-2bac-4304-a422-a60c36bba4961
209443MAPAP Extra Strength 500 MG Oral TabletPSN72053f9e-cca7-7e8a-e053-2995a90a99f01
209443MAPAP Extra Strength 500 MG Oral TabletPSNc952efb5-2bac-4304-a422-a60c36bba4961
209443acetaminophen 500 MG Oral Tablet [Mapap]SBD72053f9e-cca7-7e8a-e053-2995a90a99f01
209443acetaminophen 500 MG Oral Tablet [Mapap]SBDc952efb5-2bac-4304-a422-a60c36bba4961
198440acetaminophen 500 MG Oral TabletSCD72053f9e-cca7-7e8a-e053-2995a90a99f01
198440acetaminophen 500 MG Oral TabletSCDc952efb5-2bac-4304-a422-a60c36bba4961
198440APAP 500 MG Oral TabletSY72053f9e-cca7-7e8a-e053-2995a90a99f01
198440APAP 500 MG Oral TabletSYc952efb5-2bac-4304-a422-a60c36bba4961
209443APAP 500 MG Oral Tablet [Mapap]SY72053f9e-cca7-7e8a-e053-2995a90a99f01
209443APAP 500 MG Oral Tablet [Mapap]SYc952efb5-2bac-4304-a422-a60c36bba4961
209443Extra Strength Mapap 500 MG Oral TabletSY72053f9e-cca7-7e8a-e053-2995a90a99f01
209443Extra Strength Mapap 500 MG Oral TabletSYc952efb5-2bac-4304-a422-a60c36bba4961
209443Mapap 500 MG Oral TabletSY72053f9e-cca7-7e8a-e053-2995a90a99f01
209443Mapap 500 MG Oral TabletSYc952efb5-2bac-4304-a422-a60c36bba4961

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0904-1988-6000904198860100 TABLET in 1 BOTTLE, PLASTIC (0904-1988-60) 100 tablet2011-05-042021-09-30NoNoCurrent